Anti-tumor activity of SKLB-0322, a novel EZH2 covalent inhibitor, in ovarian cancer. This is an ASCO Meeting Abstract from the 2021 ASCO Annual Meeting I. This abstract does not include a full text ...
chemical substances in the universe, but it is thought that humans have been able to identify only 1% of them so far. It is expected that new chemical substances that have not been discovered so far ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results